Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, January 29, 2025
Kenox Pharmaceuticals Inc. announced the addition of small scale non-sterile GMP capabilities to support GLP pre-clinical studies to its comprehensive suite of drug development services.
read more
Wednesday, September 10, 2025
Strides Pharma Science announced that its subsidiary, Strides Pharma Global Pte. Limited, Singapore, has entered into a strategic product development partnership with Kenox Pharmaceuticals, a contract development and manufacturing company ...
read more
Kenco, a third-party logistics (3PL) provider, has partnered with QPharma, a provider of cloud-based compliance solutions, to add pharmaceutical sample fulfillment to their Life Sciences Division.
read more
Friday, December 07, 2012
Ken Phelps, one of the nation’s leading experts in the 505(b)(2) development pathway, will be a keynote speaker at the EPPIC Annual Conference in San Francisco, January 6.
read more
Kemwell Biopharma announced it has manufactured and supplied drug substance in India for clinical trials that will be performed by its customer in USA for an IND filing.
read more
Thursday, October 08, 2020
KemPharm has expanded its relationship with Corium through a new consultation services agreement under which KemPharm will provide product development consultation services to Corium.
read more
Kedrion has formed a research partnership with Columbia University Irving Medical Center to develop and test a new IgG therapy for COVID-19.
read more
Friday, November 13, 2020
KDx has selected Acupath Laboratories to process urine specimens for a formal FDA trial that kicked off in Q3.
read more
Monday, September 12, 2022
KCAS Bioanalytical and Biomarker Services (KCAS), a bioanalytical contract research organization (CRO), backed by Vitruvian Partners, closed the purchase of Active Biomarkers, located in Lyon, France.
read more
Monday, September 08, 2025
KBI Biopharma announced a collaboration to advance manufacturing of Infinimmune’s lead human monoclonal antibody (“IFX-101”) program.
read more
Tuesday, December 03, 2024
KBI Biopharma, Inc. announced a manufacturing contract with Alanis Therapeutics, Inc. (ATI) for the development of an innovative pre-clinical therapeutic antibody to treat myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) blood cancers...
read more
KBI Biopharma SA (KBI) and Selexis SA, both JSR Life Sciences companies, announced that an expanded, fully-integrated mammalian contract development and manufacturing services facility is now open and operational in Geneva, Switzerland.
read more
KBI Biopharma and Selexis SA, both JSR Life Sciences companies, announced the appointment of J.D. Mowery as Chief Executive Officer (CEO).
read more
Monday, December 03, 2018
KBI Biopharma and Selexis have appointed four leading, internationally recognized scientists to their newly formed Joint Scientific Advisory Board (JSAB).
read more
KBI Biopharma Inc., a JSR Life Sciences company, and AM-Pharma, an emerging leader focused on the development of therapeutics that protect organ function in patients with severe medical conditions, have signed a commercial manufacturing agreement to ...
read more